极早期药物终止妊娠的有效性与安全性:一项队列研究
该回顾性病例笔记研究纳入2004-14年维也纳和2012-15年哥德堡两妇科诊所妊娠≤49天行药物终止妊娠的女性,比较超声确认宫内妊娠组与未确认组。未确认组成功率98.2%,确认组97.1%,风险差1.09%(95%CI -0.14, 2.32%;P=0.077);确认组因不全流产接受手术或额外米索前列醇治疗者显著更多(4.3% vs 1.8%;风险差-2.42%;95%CI -3.9, -1.1%;P<0.001)。
要点
- 未确认宫内妊娠即行药物终止妊娠的有效率与确认后相当。
- 确认宫内妊娠组因不全流产接受干预的比例显著高于未确认组。
- 未确认宫内妊娠前治疗需考虑异位妊娠风险,结构化临床方案可能提高无症状期异位妊娠早期检出。
核心结论
- 两组药物终止妊娠的有效性无差异,而未确认宫内妊娠即早期治疗者因不全流产接受的干预显著更少。
- 若在确认宫内妊娠前开始治疗,需考虑异位妊娠风险,但结构化临床方案可能提高无症状期异位妊娠的早期检出。
研究设计与样本
- 回顾性病例笔记研究,设置于奥地利维也纳和瑞典哥德堡两家妇科诊所。
- 研究对象为2004-14年(维也纳)和2012-15年(哥德堡)妊娠≤49天行药物终止妊娠的所有女性。
- 创建两个队列:确认宫内妊娠组和未确认宫内妊娠组;宫内妊娠定义为超声可见卵黄囊或胎儿结构位于宫内。
- 确认宫内妊娠组女性经随机选取纳入。
- 排除11例诊断为异位妊娠或葡萄胎妊娠的女性后,最终分析纳入2643例。
主要发现
- 未确认宫内妊娠组1120例(98.2%)终止妊娠成功,确认宫内妊娠组1458例(97.1%)成功,风险差1.09%(95%CI -0.14, 2.32%;P=0.077)。
- 确认宫内妊娠组因不全流产接受手术或额外米索前列醇治疗者显著更多:64例(4.3%)vs 21例(1.8%);风险差-2.42%;95%CI -3.9, -1.1%;P<0.001。
关键数值与推荐
- 药物终止妊娠有效性定义为无继续妊娠且无需因不全流产手术。
- 宫内妊娠定义为超声可见卵黄囊或胎儿结构位于宫内。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the efficacy and safety of medical termination of pregnancy (MTOP) when no intrauterine pregnancy (IUP) is confirmed on ultrasound. DESIGN: Retrospective case-note review. SETTING: Two gynaecological clinics in Vienna, Austria, and Gothenburg, Sweden. POPULATION: All women with gestations of ≤49 days undergoing an MTOP during 2004-14 (Vienna) and 2012-15 (Gothenburg). METHODS: Two study cohorts were created: women with and women without a confirmed IUP. An IUP was defined as the intrauterine location of a yolk sac or fetal structure visible by ultrasound. Women with an IUP were selected randomly and included in the IUP cohort. MAIN OUTCOME MEASURES: Efficacy of MTOP, defined as no continuing pregnancy and with no need of surgery for incomplete TOP. RESULTS: After excluding 11 women diagnosed with an extra-uterine or molar pregnancy, 2643 cases were included in the final analysis; 1120 (98.2%) had a successful TOP in the no-IUP group, compared with 1458 (97.1%) in the IUP group, with a risk difference of 1.09% (95% confidence interval, 95% CI, -0.14, 2.32%; P = 0.077). Significantly more women with confirmed IUP were diagnosed with incomplete TOP, and were treated with either surgery or additional medical treatment of misoprostol [64 (4.3%) versus 21 (1.8%); risk difference -2.42%; 95% CI -3.9, -1.1%; P < 0.001]. CONCLUSIONS: There was no difference between the groups in efficacy of MTOP, whereas early treatment resulted in significantly fewer interventions for incomplete TOP. The risk of ectopic pregnancy needs to be considered if treatment is initiated before an IUP is confirmed, but with structured clinical protocols the possibility of the early detection of an ectopic pregnancy in an asymptomatic phase may increase. TWEETABLE ABSTRACT: MTOP before confirmed intrauterine pregnancy is as effective as at later gestation with less incomplete TOP.
引用
- Bizjak I, Fiala C, Berggren L, et al. Efficacy and safety of very early medical termination of pregnancy: a cohort study. BJOG. 2017. PMID: 28856829. doi:10.1111/1471-0528.14904
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。